M. Feldman, H. Grimaudo, S. Roth, H. Vance, A. Daniels, M. Froehler
{"title":"P-028视网膜母细胞瘤动脉内治疗的眼动脉血流方向改变","authors":"M. Feldman, H. Grimaudo, S. Roth, H. Vance, A. Daniels, M. Froehler","doi":"10.1136/neurintsurg-2021-snis.64","DOIUrl":null,"url":null,"abstract":"(DMSO)). Aqua Embolic System (AES) is a new LEM, which is mainly composed of multiple polysaccharides. AES, when injected via a microcatheter, immediately forms a solid and elastic hydrogel cast upon exposure to Ca2+ in the bloodstream. The use of organic solvents, e.g., DMSO, is not required. The performance of AES was evaluated using an established AVM model utilizing swine rete-mirabile. Methods Under general anesthesia, the left ascending pharyngeal artery (APA) of Yorkshire swine (40 kg) was catheterized using a microcatheter (ID:0.013 inches), and AES was slowly injected into the rete-mirabile under fluoroscopy. The following parameters were assessed to evaluate the embolization performance of the AES; 1) the amount of AES required for the complete occlusion of the feeding artery, 2) injection speed, 3) radiopacity during the deployment, and 4) incidence of catheter entrapment after the injection. The same evaluation was performed on the contralateral rete-mirabile and the left renal artery as well. Results 12 arteries in 4 swine were treated, and all arteries were completely occluded without technical complications. The injected materials immediately formed AES cast in all vessels, followed by the reflux over the tip of the microcatheter. All catheters were withdrawn without any sign of catheter entrapment. The AES mixed with tantalum-based contrasts medium showed sufficient radiopacity under fluoroscopy. With the injection speed of 0.02ml/sec, the average volume required was 0.85mL for the APA and 2.9mL for the renal artery. No increased thrombogenicity or vasospasm near the treated lesion was observed during the procedure. Conclusions AES, which is a DMSO free, non-adhesive polysaccharides based LEM, may be used as an embolic material for the treatment of hemorrhagic stroke caused by cerebrovascular diseases, such as brain AVM. A: common carotid artery injection (AP view) shows left ascending pharyngeal artery (APA) and left rete mirabile (red arrow). B: AES is injected from the microcatheter. The AES reflux is reaching the tip of the microcatheter. C: With continuous injection of AES, the microcotheter tip is embedded ¡n the cost of AES. D. Post treatment angiogram shows complete occlusion of the left rete mirabile and APA Disclosures I. Yuki: 1; C; ICTS Grant, POP Grant. K. Ohkawa: None. S. Li: None. E. Steward: None. B. Nguyen: None. F. Hsu: None. J. Xu: None. S. Suzuki: None.","PeriodicalId":341680,"journal":{"name":"Oral poster abstracts","volume":"70 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"P-028 Ophthalmic artery flow direction changes in intra-arterial treatment of retinoblastoma\",\"authors\":\"M. Feldman, H. Grimaudo, S. Roth, H. Vance, A. Daniels, M. Froehler\",\"doi\":\"10.1136/neurintsurg-2021-snis.64\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"(DMSO)). Aqua Embolic System (AES) is a new LEM, which is mainly composed of multiple polysaccharides. AES, when injected via a microcatheter, immediately forms a solid and elastic hydrogel cast upon exposure to Ca2+ in the bloodstream. The use of organic solvents, e.g., DMSO, is not required. The performance of AES was evaluated using an established AVM model utilizing swine rete-mirabile. Methods Under general anesthesia, the left ascending pharyngeal artery (APA) of Yorkshire swine (40 kg) was catheterized using a microcatheter (ID:0.013 inches), and AES was slowly injected into the rete-mirabile under fluoroscopy. The following parameters were assessed to evaluate the embolization performance of the AES; 1) the amount of AES required for the complete occlusion of the feeding artery, 2) injection speed, 3) radiopacity during the deployment, and 4) incidence of catheter entrapment after the injection. The same evaluation was performed on the contralateral rete-mirabile and the left renal artery as well. Results 12 arteries in 4 swine were treated, and all arteries were completely occluded without technical complications. The injected materials immediately formed AES cast in all vessels, followed by the reflux over the tip of the microcatheter. All catheters were withdrawn without any sign of catheter entrapment. The AES mixed with tantalum-based contrasts medium showed sufficient radiopacity under fluoroscopy. With the injection speed of 0.02ml/sec, the average volume required was 0.85mL for the APA and 2.9mL for the renal artery. No increased thrombogenicity or vasospasm near the treated lesion was observed during the procedure. Conclusions AES, which is a DMSO free, non-adhesive polysaccharides based LEM, may be used as an embolic material for the treatment of hemorrhagic stroke caused by cerebrovascular diseases, such as brain AVM. A: common carotid artery injection (AP view) shows left ascending pharyngeal artery (APA) and left rete mirabile (red arrow). B: AES is injected from the microcatheter. The AES reflux is reaching the tip of the microcatheter. C: With continuous injection of AES, the microcotheter tip is embedded ¡n the cost of AES. D. Post treatment angiogram shows complete occlusion of the left rete mirabile and APA Disclosures I. Yuki: 1; C; ICTS Grant, POP Grant. K. Ohkawa: None. S. Li: None. E. Steward: None. B. Nguyen: None. F. Hsu: None. J. Xu: None. S. Suzuki: None.\",\"PeriodicalId\":341680,\"journal\":{\"name\":\"Oral poster abstracts\",\"volume\":\"70 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-07-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Oral poster abstracts\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/neurintsurg-2021-snis.64\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oral poster abstracts","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/neurintsurg-2021-snis.64","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
摘要
(DMSO))。Aqua Embolic System (AES)是一种主要由多种多糖组成的新型LEM。当通过微导管注射AES时,暴露于血液中的Ca2+后立即形成固体和弹性水凝胶。不需要使用有机溶剂,例如二甲基亚砜。利用建立的AVM模型对AES的性能进行了评价。方法在全身麻醉下,用微导管(ID:0.013英寸)置管约克郡猪(40 kg)咽左升动脉(APA),在透视下缓慢注射AES。评估以下参数以评价AES的栓塞性能;1)完全闭塞供血动脉所需的AES量,2)注射速度,3)部署时的放射线不透明,4)注射后导管夹持的发生率。对侧肾动脉和左肾动脉也进行了同样的评估。结果4头猪12条动脉全部闭塞,无技术并发症。注入的材料立即在所有血管中形成AES铸型,随后在微导管尖端回流。所有导管均拔出,无任何导管夹持迹象。AES与钽基对比剂混合在透视下显示出足够的放射不透性。注射速度为0.02ml/sec时,APA平均所需体积为0.85mL,肾动脉平均所需体积为2.9mL。在手术过程中未观察到治疗病灶附近血栓形成性增加或血管痉挛。结论AES是一种不含DMSO的无黏附多糖LEM,可作为脑动静脉畸形等脑血管疾病所致出血性卒中的栓塞材料。A:颈总动脉注射(AP视图)显示左侧咽升动脉(APA)和左侧奇迹动脉(红色箭头)。B: AES从微导管注射。AES反流到达微导管尖端。C:连续注入AES,微针尖嵌入AES成本。D.治疗后血管造影显示左远端完全闭塞和APA披露。C;信息通信技术基金,流行基金。K.大川:没有。S.李:没有。E. Steward:没有。B. Nguyen:没有。徐:没有。J. Xu:没有。铃木:没有。
P-028 Ophthalmic artery flow direction changes in intra-arterial treatment of retinoblastoma
(DMSO)). Aqua Embolic System (AES) is a new LEM, which is mainly composed of multiple polysaccharides. AES, when injected via a microcatheter, immediately forms a solid and elastic hydrogel cast upon exposure to Ca2+ in the bloodstream. The use of organic solvents, e.g., DMSO, is not required. The performance of AES was evaluated using an established AVM model utilizing swine rete-mirabile. Methods Under general anesthesia, the left ascending pharyngeal artery (APA) of Yorkshire swine (40 kg) was catheterized using a microcatheter (ID:0.013 inches), and AES was slowly injected into the rete-mirabile under fluoroscopy. The following parameters were assessed to evaluate the embolization performance of the AES; 1) the amount of AES required for the complete occlusion of the feeding artery, 2) injection speed, 3) radiopacity during the deployment, and 4) incidence of catheter entrapment after the injection. The same evaluation was performed on the contralateral rete-mirabile and the left renal artery as well. Results 12 arteries in 4 swine were treated, and all arteries were completely occluded without technical complications. The injected materials immediately formed AES cast in all vessels, followed by the reflux over the tip of the microcatheter. All catheters were withdrawn without any sign of catheter entrapment. The AES mixed with tantalum-based contrasts medium showed sufficient radiopacity under fluoroscopy. With the injection speed of 0.02ml/sec, the average volume required was 0.85mL for the APA and 2.9mL for the renal artery. No increased thrombogenicity or vasospasm near the treated lesion was observed during the procedure. Conclusions AES, which is a DMSO free, non-adhesive polysaccharides based LEM, may be used as an embolic material for the treatment of hemorrhagic stroke caused by cerebrovascular diseases, such as brain AVM. A: common carotid artery injection (AP view) shows left ascending pharyngeal artery (APA) and left rete mirabile (red arrow). B: AES is injected from the microcatheter. The AES reflux is reaching the tip of the microcatheter. C: With continuous injection of AES, the microcotheter tip is embedded ¡n the cost of AES. D. Post treatment angiogram shows complete occlusion of the left rete mirabile and APA Disclosures I. Yuki: 1; C; ICTS Grant, POP Grant. K. Ohkawa: None. S. Li: None. E. Steward: None. B. Nguyen: None. F. Hsu: None. J. Xu: None. S. Suzuki: None.